Abstract: A method for preparing ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages. The method comprises nanolipidic vehicles in which ethanol-containing substances are encapsulated, said ethanol-containing nanolipidic vehicles can be combined with food products, desserts or beverage ingredients including those that are subsequently frozen. The food product, dessert or beverage can remain in a frozen state during consumption by an individual. A composition comprising ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages.
Abstract: A method for preparing ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages. The method comprises nanolipidic vehicles in which ethanol-containing substances are encapsulated, said ethanol-containing nanolipidic vehicles can be combined with food products, desserts or beverage ingredients including those that are subsequently frozen. The food product, dessert or beverage can remain in a frozen state during consumption by an individual. A composition comprising ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages.
Abstract: The present invention relates to a process for manufacturing pullulan hard capsules having improved film properties. More particularly, the present invention relates to a process for manufacturing pullulan hard capsules having improved film properties by solving the problems, such as, sticky among pullulan hard capsules, storage stability and/or brittleness.
Abstract: The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity or an obesity associated disorder.
Type:
Grant
Filed:
March 2, 2016
Date of Patent:
March 19, 2019
Assignee:
SANIONA A/S
Inventors:
Peter G. Nielsen, Mikael S. Thomsen, Bent Højgaard
Abstract: The present invention relates to a composition comprising a lithium salt of an N-substituted glycine compound and a carrier, wherein the lithium salt of the N-substituted glycine compound is of Formula (I): in which R1, R2, and R3 each are independently hydrogen, alkyl, alkenyl, alkynyl, aralkyl, carbocyclyl, aryl, or heteroaryl, or one of R1, R2, and R3 is absent. Also provided in the present invention is a method of mitigating at least one symptom of a neuropsychiatric disorder, comprising administering to a subject in need thereof the lithium salt of an N-substituted glycine compound of Formula (I).
Type:
Grant
Filed:
July 10, 2017
Date of Patent:
March 12, 2019
Assignee:
SyneuRx International (Taiwan) Corp.
Inventors:
Guochuan Emil Tsai, Ching-Hsun Huang, Han-Yi Hsieh, Jing-Jia Huang, Ching-Cheng Wang
Abstract: Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.
Type:
Grant
Filed:
June 27, 2017
Date of Patent:
March 12, 2019
Assignee:
MicroVention, Inc.
Inventors:
Gregory M. Cruise, Michael J. Constant, Terrance Tran
Abstract: Described are devices for implantation comprising a hydrogel filament wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer, an ethylenically unsaturated monomer, and a visualization agent. Methods of making and using these devices are also described.
Type:
Grant
Filed:
September 21, 2016
Date of Patent:
February 5, 2019
Assignee:
MicroVention, Inc.
Inventors:
Gregory M. Cruise, Michael J. Constant, Edward Michael Keeley, Terrance T. Tran
Abstract: An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described.
Abstract: Methods of making personal care compositions, such as dentifrices, involving the addition of rheology modifiers at a later stage in the personal care composition formation process.
Type:
Grant
Filed:
October 24, 2014
Date of Patent:
January 8, 2019
Assignee:
THE PROCTER & GAMBLE COMPANY
Inventors:
Mark Lewis Agerton, Steven Robert Alexander, Gina Lynn Blum, Marco Caggioni, Susan Marie Dawes, David Michael Farren, Justin Thomas Lydon Hedin, Charles Phillip Miller, Christa Marie Novicki, Melissa Cherie Payne, Molly Rose Schottelkotte, John Christopher Wesner, Randall Lee Wood
Abstract: Provided are compositions and methods that are useful for hair care compositions. The compositions comprise polyurethane microparticles coated with zinc salt particles, wherein the ratio of zinc salt to polyurethane is in a range of from 1:99 to 3:7, and the polyurethane microparticles have an average particle size of less than 100 microns. Also provided are methods of preparation of such compositions.
Type:
Grant
Filed:
December 2, 2014
Date of Patent:
January 1, 2019
Assignees:
Dow Global Technologies LLC, Rohm and Haas Company
Inventors:
Wai Kin Lee, Wei Lu, Wuye Ouyang, Xiao Yi Pang, Tong Sun, Xianda Xiao, Shiling Zhang
Abstract: Ophthalmic formulations containing tyrosine kinase inhibitors, such as Nintedanib, Axitinib, Sorafenib, and Pazopanib are described. The ophthalmic formulations can contain microparticles or nanoparticles of the tyrosine kinase inhibitor. Also described are methods of using the ophthalmic formulations for treating ocular surface diseases, such pterygium, including recurrent pterygium, and hyperemia associated with pterygium.
Abstract: A shampoo composition that increases the deposition and retention of benefit agent containing polyacrylate microcapsules onto hair during the cleansing process. The shampoo composition is based on the combination of anionic charged polyacrylate microcapsules, cationic deposition polymers, detersive surfactant, and a carrier.
Type:
Grant
Filed:
November 13, 2014
Date of Patent:
December 4, 2018
Assignee:
The Procter and Gamble Company
Inventors:
Jiten Odhavji Dihora, Mark Anthony Brown
Abstract: The present invention is a composition and method for making and using a rechargeable multifunctional additive that reduce the formation of biofilms on a surface, the additive can also remain photo and thermally stable by synthesizing one or more N-halamine compounds and adding one or more N-halamine biocidal compounds to a target material prior, during or after the target material is made. The resultant material can be used directly to provide antimicrobial functions and control biofilm formation, or the material can be further processed into an article.
Type:
Grant
Filed:
December 23, 2014
Date of Patent:
November 27, 2018
Assignee:
Board of Regents, The University of Texas System
Abstract: A method of enhancing therapeutic/drug transport to the perivascular space of the brain of a patient is disclosed. In one embodiment, the method comprises the step of introducing a therapeutic/drug and an osmolyte of the present invention into a patient's cerebrospinal fluid (CSF), wherein the osmolyte is introduced to the CSF at a concentration of between 0.5 and 12.9 M (dependent on the solubility upper limit of the osmolyte), and wherein the therapeutic/drug delivery to the perivascular spaces of cerebral blood vessels and parenchyma of the central nervous system is facilitated by the presence of the osmolyte.
Type:
Grant
Filed:
October 14, 2016
Date of Patent:
November 13, 2018
Assignee:
Wisconsin Alumni Research Foundation
Inventors:
Robert G. Thorne, Michelle E. Pizzo, Daniel J. Wolak
Abstract: The present invention comprises systems, methods and devices for the delivery of compositions for occluding or of means for opening conduits. The implantable occlusive material may be delivered pre-formed or in situ cured and, may be a resorbable material that supports tissue ingrowth that eventually replaces the material leaving little or no original material in place. The delivery system is positioned to allow for placement of the occlusive material into the body conduit. Use of delivery systems, methods and devices for re-opening an occluded body conduit are also included.
Type:
Grant
Filed:
October 25, 2017
Date of Patent:
October 30, 2018
Assignee:
FEMASYS, INC.
Inventors:
Kathy Lee-Sepsick, Lani L. L. Paxton, Jeffrey A. Marcus, Stephen N. Williams
Abstract: An aqueous disinfectant formulation comprising at least one phenolic compound of natural origin; a surfactant sufficient to form a solution or dispersion of the essential oil in an aqueous carrier; a solvent, and sufficient water to make 100 weight percent is described herein.
Type:
Grant
Filed:
December 28, 2016
Date of Patent:
October 30, 2018
Inventors:
Francois Daigle, Ann Letellier, Sylvain Quessy
Abstract: A particulate, modified release barrier coated drug-cation exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. Methods of making and products containing this coated complex are described.
Abstract: Embodiments described herein generally relate to medicinal compositions (e.g., compositions comprising an active pharmaceutical agent) such as those comprising liquid hydrogen and/or hydrogen gas. In certain embodiments, the composition comprises hydrogen and/or noble gas(es) in a medicinal composition, for example, within the aqueous phase (e.g., dissolved). For example, in some cases, the medicinal composition may comprise an active pharmaceutical ingredient and hydrogen (H2) and/or noble gas(es). The noble gas may be, for example, xenon, argon, or the like. In some embodiments, the hydrogen and/or the noble gas(es) may infuse with the composition (e.g., such that at least a portion of the hydrogen gas and/or noble gas(es) is dissolved within the composition). Such compositions comprising hydrogen gas and/or noble gas(es) may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like.
Abstract: Antiseptic hand rub composition comprising at least 0.2% w/w of isopropyl myristate, free from other derivatives of myristic acid. Phenoxyethanol is preferably present in the composition at a concentration of 1% by wt or less. A glycol may also be present, such as dipropylene glycol if the composition is an ethanol based hand rub gel or propylene glycol if the composition is in the form of an emulsion or dispersion. Additional biocides such as triclosan and chlorhexidine gluconate may be included.
Abstract: The present invention provides a composition including a polymer nanoparticle and at least one agricultural active compound incorporated with the nanoparticle, wherein the nanoparticle are less than 100 nm in diameter, and the polymer includes a polyelectrolyte.
Type:
Grant
Filed:
April 5, 2017
Date of Patent:
September 11, 2018
Assignee:
Vive Crop Protection Inc.
Inventors:
Fugang Li, Hung Hoang Pham, Darren J. Anderson